sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> prescription pharmaceuticals market

report

Prescription Pharmaceuticals Market, by Therapeutic Segments (Cardiovascular Disorders, Inflammatory Conditions, Metabolic Disorders, Oncology, Respiratory Disorders, Others), Formulations (Capsules, Inhalants, Parenterals, Tablets, Topicals) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2020

HC101 October 2016 96 FREE 10% CUSTOMIZATION

Prescription Pharmaceuticals Market to grow from USD 761.85 billion in 2016 and reach USD 918.74 billion by 2020, growing at a CAGR of 4.8% during the forecast period.

Our industry experts anticipate that within the prescription pharmaceuticals market, the infectious disease will be the fastest-growing therapeutic segment, growing at a CAGR ranging from 5% to 10% by 2020. In addition, capsules will be the largest as well as the fastest-growing formulation segment, growing at a CAGR ranging from 5% to 10% by 2020. The Asia-Pacific region will be the fastest-growing geographic segment of the market, growing at a CAGR of more than 6% during the forecast period.

KEY BENEFITS OF THE REPORT

  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players and innovators influencing this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The increase in the aging population and lengthening life expectancies, the rising affluence in the emerging markets and the widespread prevalence of the chronic diseases are the major drivers of the prescription pharmaceuticals market.
  • The evolution of the population structure will increase the pressure on the long-term publicly-funded health support programs for the elderly, driving the demand for the prescription pharmaceuticals market.
  • There will be a paradigm shift from the acute to chronic illnesses, thereby leading to an increased use of the prescription pharmaceuticals. Chronic diseases, namely, heart diseases, strokes, cancer, type 2 diabetes, obesity, and arthritis pose a serious threat to the health of the world population.
  • The factors such as the rising average age of the population and the changing epidemiologic profile of the global population are the major contributors to the high prevalence of the chronic diseases.
  • The management of chronic diseases is costly, primarily due to the high cost of the prescription pharmaceuticals. For instance, the cost of the management of diabetes is projected to increase to USD 745 billion by 2030.
  • The rise in the generic and biosimilar products and the changing government policies will act as the major restraints for the growth of this market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s prescription pharmaceuticals market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the prescription pharmaceuticals market by the following segments:

  • Prescription Pharmaceuticals Market, by Therapeutic Segments
    • Cardiovascular Disorders
    • Oncology
    • Inflammatory Conditions
    • Infectious Diseases
    • Metabolic Disorders
    • Respiratory Disorders
    • Other Therapeutic Segments
  • Prescription Pharmaceuticals Market, by Formulations
    • Capsules
    • Tablets
    • Inhalants and Liquids
    • Parenterals
    • Topicals

KEY MARKET PLAYERS

Key players in the prescription pharmaceuticals market include:

  • AG, Gilead Sciences, Inc.
  • AstraZeneca plc
  • GlaxoSmithKline plc,
  • Johnson & Johnson,
  • Merck & Co, A.G.,
  • Pfizer, Inc.
  • F. Hoffmann-La Roche

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

Prescription Pharmaceuticals Market

TRENDING RELATED REPORT

Home Healthcare Market, by Products (Patient Diagnosis/Treatment Devices, Assistive Technology Based Devices and Enteral Feeding Devices), Services (Rehabilitation, Home Respiratory Therapy, Home Infusion Therapy, Telehealth and Unskilled Home Healthcare Services) - Global Revenue, Trends, Growth, Share, Size & Forecast to 2021


1. EXECUTIVE SUMMARY

1.1. Research Scope

1.1.1. Market Definitions

1.1.2. Market Segmentation

1.1.3. Research Methodology

1.2. Executive Summary

1.2.1. Market Summary

1.2.2. Comparative Analysis

2. MARKET DYNAMICS

2.1. Drivers

2.2. Restraints

2.3. Opportunities

2.4. Trends

3. INDUSTRY ANALYSIS

3.1. Value Chain Analysis

3.2. Regulatory Analysis

3.3. Reimbursement Landscape

3.4. Product Roadmap

4. PRESCRIPTION PHARMACEUTICALS MARKET, BY THERAPEUTIC SEGMENTS

4.1. Introduction

4.2. Cardiovascular Disorders

4.3. Oncology

4.4. Inflammatory Conditions

4.5. Infectious Diseases

4.6. Metabolic Disorders

4.7. Respiratory Disorders

4.8. Other Therapeutic Segments

5. PRESCRIPTION PHARMACEUTICALS MARKET, BY FORMULATIONS

5.1. Introduction

5.2. Capsules

5.3. Tablets

5.4. Inhalants and Liquids

5.5. Parenterals

5.6. Topicals

6. PRESCRIPTION PHARMACEUTICALS MARKET, BY GEOGRAPHY

6.1. Introduction

6.2. North America

6.2.1. U.S.

6.2.2. Canada

6.3. Europe

6.3.1. France

6.3.2. Germany

6.3.3. U.K

6.3.4. Rest of Europe

6.4. Asia-Pacific

6.4.1. China

6.4.2. India

6.4.3. Japan

6.4.4. Rest of Asia-Pacific

6.5.Rest of the World

6.5.1. Latin America

6.5.2. Middle East and Africa

7. COMPETITIVE LANDSCAPE

7.1. Market Share Analysis

7.2. Market Positioning of Key Players

8. KEY MARKET PLAYERS

8.1. AstraZeneca

8.2. Bayer AG

8.3. Gilead Sciences

8.4. GlaxoSmithKline

8.5. Johnson & Johnson

8.6. Merck & Co

8.7. Novartis A.G.

8.8. Pfizer

8.9. F. Hoffmann-La Roche AG

8.10. Sanofi

9. SCALAR 360 DEGREE MARKET PERSPECTIVE

10. APPENDIX

Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us